# Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis

> **NCT00690885** · PHASE2 · TERMINATED · sponsor: **Ainos, Inc. (f/k/a Amarillo Biosciences Inc.** · enrollment: 1 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive
- Pulmonary Fibrosis
- Cough

## Interventions

- **DRUG:** interferon-alpha lozenges
- **DRUG:** placebo lozenges

## Key facts

- **NCT ID:** NCT00690885
- **Lead sponsor:** Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-06
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Insufficient patient accrual
- **Last updated:** 2012-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00690885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00690885, "Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00690885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*